Onconetix, Inc. Common Stock
Symbol: ONCO (NASDAQ)
3.38
▼ (-1.46%) -0.050
Company Description:
Onconetix Inc is a commercial-stage biotechnology company focused on the research, development, and commercialization of solutions for men's health and oncology. It has a product named Entadfi an FDA-approved once-daily oral therapeutic for the treatment of benign prostatic hyperplasia, a disorder of the prostate, along with building additional assets in therapeutics, diagnostics, and clinician services for oncology.
Key Stats
- Today's Open: $3.44
- Today's High: $3.553
- Today's Low: $3.25
- Today's Volume: 1.27K
- Yesterday Close: $3.43
- Yesterday High: $3.44
- Yesterday Low: $3.2521
- Yesterday Volume: 5.44K
- Last Min Volume: 1
- Last Min High: $3.38
- Last Min Low: $3.38
- Last Min VWAP: $3.38
Company Profile
- Name: Onconetix, Inc. Common Stock
- Website: https://www.onconetix.com
- Listed Date: 2022-02-18
- Location: CINCINNATI, OH
- Market Status: Active
- CIK Number: 0001782107
- SIC Code: 2834
- SIC description: PHARMACEUTICAL PREPARATIONS
- Market Cap: $5.33M
- Round Lot: 100
- Outstanding Shares: 1.56M
- Asset Type: CS
RECENT FILINGS FOR ONCO
| Filing Date | Filing Type | Format |
|---|---|---|
| 2025-10-16 | S-1 | View |
| 2025-10-07 | D | View |
| 2025-10-03 | 8-K | View |
| 2025-09-26 | 8-K | View |
| 2025-09-22 | 8-K | View |
| 2025-09-04 | 8-K | View |
| 2025-08-19 | 4 | View |
| 2025-08-19 | 4 | View |
| 2025-08-19 | 4 | View |
| 2025-08-19 | 4 | View |
| 2025-08-14 | 10-Q | View |
| 2025-08-12 | 8-K | View |
| 2025-07-16 | 4 | View |
| 2025-07-16 | SCHEDULE 13D/A | View |
| 2025-07-16 | 8-K | View |
| 2025-06-16 | 8-K | View |
| 2025-06-12 | 10-Q | View |
| 2025-06-11 | 8-K | View |
| 2025-06-05 | 8-K | View |
| 2025-06-02 | 10-K | View |
Latest News on ONCO